| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.2 |